Search alternatives:
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
361
-
362
-
363
-
364
MAP-2 decrease follows the early PSA-NCAM reduction induced by glutamate exposure.
Published 2014“…MAP-2 and PSA-NCAM immunoreactive areas are expressed as mean values (±SEM) of 20–30 neurons per experimental condition. ns, non-significant; *** P<0.001 between bars, non-parametric Mann-Whitney test. …”
-
365
-
366
-
367
-
368
Postnatal CDPPB treatment decreased [<sup>11</sup>C]PBR accumulation in saline-exposed offspring, but not in offspring prenatally exposed to LPS.
Published 2015“…<p>Postnatal CDPPB treatment decreased the accumulation of [<sup>11</sup>C]PBR in the olfactory bulb, cerebellum, hippocampus, striatum, hypothalamus and the whole brain of the offspring prenatally exposed to saline solution (A). …”
-
369
Twenty-four hour monitoring revealed increased interaction and decreased activity during daytime in <i>Cdkl5</i> -/Y mice.
Published 2018“…<p>(A) (i) Mean number of particles. <i>Cdkl5</i> -/Y mice spend significantly more time staying together compared to <i>Cdkl5</i> +/Y mice during daytime (p < 0.001), but not in the nighttime (p = 0.2436). …”
-
370
-
371
Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients
Published 2014“…We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state.</p><p>Results</p><p>The Ecuadorian non-diabetic controls appeared as overweight (BMI>25: patients 85%, controls 82.5%) and as dyslipidemic (hypercholesterolemia: patients 60.7%, controls 67.5%) as the patients.…”
-
372
-
373
-
374
Decreased brain glucose uptake and glucose transporter expressions at early stage of female aging.
Published 2013“…<p>A. Representative FDG-microPET images showed an age-related decline in brain glucose uptake in nonTg brain, which was maximal between 6 and 9 months of age. …”
-
375
-
376
-
377
-
378
-
379
-
380
Eltrombopag markedly decreases levels of ROS in MOLM14 cells.
Published 2015“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”